GJA1/CX43/Connexin 43 (C-Terminus) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-GJA1/CX43/Connexin 43 (C-Terminus) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | GJA1/CX43/Connexin 43 (C-Terminus) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | humanpredicted: chicken, bovine, rabbit, mouse, dog, rat |
| Isotype | n/a |
| Format | immunoaffinity purified |
| Size | 0.05 mL |
| Concentration | n/a |
| Applications | Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC) Paraffin, Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Recognizes endogenous levels of Connexin 43 protein. Gap junction protein that acts as a regulator of bladder capacity. Agap junction consists of a cluster of closely packed pairs oftransmembrane channels, the connexons, through which materials of low MWdiffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling ofpotassium to the cochlear endolymph. |
| Immunogen | Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human Connexin 43. Conjugation: Unconjugated |
| Other Names | [Rabbit to Human GJA1/CX43/Connexin 43; GJA1; Connexin-43; DFNB38; Connexin 43; Gap junction alpha-1 protein; GJAL; HSS; Gap junction protein alpha 1; ODDD; ODD; AVSD3; CX43; HLHS1; ODOD; SDTY3] |
| Gene, Accession # | [GJA1], Gene ID: 2697, NCBI: NP_000156.1, UniProt: P17302 |
| Catalog # | MBS2401669 |
| Price | $530 |
| Order / More Info | GJA1/CX43/Connexin 43 (C-Terminus) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies